Related Experiment Videos
Beta-agonists modulate T-cell functions via direct actions on type 1 and type 2 cells
Matthew J Loza1, Susan Foster, Stephen P Peters
1Department of Internal Medicine, Center for Human Genomics, Wake Forest University School of Medicine, Medical Center Blvd, Winston-Salem, NC 27157, USA.
Blood
|November 10, 2005
Summary
Beta-agonists directly activate beta2-adrenergic receptors (beta2AR) on T cells, modulating immune responses. This study reveals complex roles for G-protein-coupled receptors (GPCRs) and protein kinase A (PKA) in T-cell subtype function.
Area of Science:
- Immunology
- Cellular Signaling
- Pharmacology
Background:
- The beta2-adrenergic receptor (beta2AR) is a well-studied G-protein-coupled receptor (GPCR).
- The impact of beta-agonists on T-cell subtype function is not fully understood.
- Previous studies suggested a lack of beta2AR expression on type 2 T cells.
Purpose of the Study:
- To investigate the direct effects of beta-agonists on T-cell subtype function.
- To explore the role of beta2AR activation in human peripheral blood lymphocytes (PBLs).
- To elucidate the signaling pathways involved in beta-agonist-mediated T-cell modulation.
Main Methods:
- Analysis of type 2 interleukin-13+ (IL-13+) T cells (CD4+ or CD8+) from human PBLs.
- Measurement of protein kinase A (PKA) activity.
- Assessment of CD25 expression and cytokine production (IL-13, IFN-gamma, IL-2) following stimulation.
- Evaluation of p38 mitogen-activated protein kinase (MAPK) phosphorylation and other signaling pathways (p42/p44, NF-kappaB).
Main Results:
- Type 2 T cells express functional beta2AR, responding to beta-agonists.
- Beta-agonist stimulation induced PKA activity and inhibited CD3-stimulated CD25 expression, IL-13, IFN-gamma, and IL-2 production.
- Prostaglandin E2 (PGE2) was more potent than beta-agonist in PKA activation and cytokine inhibition.
- Differential regulation of signaling pathways explained the selective inhibition of IFN-gamma and IL-13.
- Low concentrations of beta-agonist and PGE2 enhanced IL-13 production, but not IFN-gamma or IL-2.
Conclusions:
- Beta2AR activation has direct effects on T-cell subtypes.
- GPCRs and PKA play complex roles in modulating T-cell functions.
- Findings challenge previous assumptions about beta2AR expression and function in T cells.